NVO Novo Nordisk A/S
Stable Earnings Power
A- 86.7 / 100 composite

AlphaQuality composite grade, weighted for stable earnings power businesses.

Profitability

Weight: 20%
A 88
  • 5yr Avg ROIC 46.6%
  • Operating Margin Trend +0.12 pp/yr

Capital Efficiency

Weight: 15%
A+ 93
  • 5yr Avg ROE 67.1%
  • 5yr Share-Count CAGR -1.0%

Growth Quality

Weight: 15%
A+ 98
  • 5yr Revenue CAGR 19.5%
  • 5yr EPS CAGR 20.6%
  • Revenue-Growth Years (5) 5/5

Cash Generation

Weight: 15%
A 89
  • 5yr FCF Margin 26.7%
  • 5yr FCF/NI Conversion 0.79x

Balance Sheet

Weight: 20%
A+ 95
  • Net Debt / EBITDA 0.66x
  • Interest Coverage (EBIT/Int) 32.03x
  • Altman Z-Score 6.19

Stability

Weight: 15%
C 55
  • EPS Volatility (σ/μ) 0.51
  • Negative-Revenue Years (5) 0/5
  • Piotroski F-Score 5

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Accumulating

3 of 3 gurus held; 3 added; 1 full exit.

Holders
3 +1
Avg Δ position
+84.6%
New buys
0
Full exits
1
As of Q2 2026